Physician Data Query (PDQ) Cancer Information summaries
Alphabetical List of PDQ® Adult Cancer Treatment Summaries

Childhood Non-Hodgkin Lymphoma (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, and treatment of childhood non-Hodgkin lymphoma (NHL).

Childhood Hodgkin Lymphoma (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, treatment, and potential late therapy effects of childhood Hodgkin lymphoma.

Ewing Family of Tumors (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, and treatment of the Ewing family of tumors (EFT). In this review, the EFT includes bone primaries (classic Ewing sarcoma, primitive neuroectodermal tumor, and Askin tumor [chest wall]), which will be...

Multiple Myeloma and Other Plasma Cell Neoplasms (PDQ®): Treatment
Multiple myeloma is a systemic malignancy of plasma cells that is highly treatable but rarely curable. It is potentially curable when it presents as a solitary plasmacytoma of bone or as an extramedullary plasmacytoma. The median survival in the prechemotherapy era was...

Adult Soft Tissue Sarcoma (PDQ®): Treatment
Soft tissue sarcomas are malignant tumors that may arise in any of the mesodermal tissues of the extremities (50%), trunk and retroperitoneum (40%), or head and neck (10%). Rarely, these tumors arise in the gastrointestinal tract or gastrointestinal stroma. Soft tissue sarcomas occur with greater frequency in patients...

Osteosarcoma/Malignant Fibrous Histiocytoma of Bone (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, and treatment of osteosarcoma and malignant fibrous histiocytoma of bone.

Childhood Soft Tissue Sarcoma (PDQ®): Treatment
This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, and treatment of childhood soft tissue sarcoma.

This cancer treatment information summary provides an overview of the prognosis, diagnosis, classification, staging, and treatment of childhood rhabdomyosarcoma.
The National Cancer Institute provides the PDQ pediatric cancer treatment information summaries as a public service to increase the availability of evidence-based cancer information to health professionals, patients, and the public....

Cellular Classification:-
Embryonal Rhabdomyosarcoma
Botryoid and spindle cell subtypes
Alveolar Rhabdomyosarcoma
Pleomorphic (Anaplastic) Rhabdomyosarcoma

Chromosomal and Molecular Characteristics
Rhabdomyosarcoma can be divided into several histologic subsets: embryonal rhabdomyosarcoma, which has embryonal, botryoid, and spindle cell subtypes; alveolar rhabdomyosarcoma; and pleomorphic rhabdomyosarcoma.

Treatment Option Overview All children with rhabdomyosarcoma require multimodality therapy with systemic chemotherapy, in conjunction with either surgery, radiation therapy, or both modalities for local tumor control.[1-3] This entails surgical resection, if feasible without major functional/cosmetic impairment, followed by chemotherapy.

Adult Hodgkin's Lymphoma (PDQ®): Treatment
More than 75% of all newly diagnosed patients with adult Hodgkin’s lymphoma (HL) can be cured with combination chemotherapy and/or radiation therapy. National mortality has fallen more rapidly for adult HL than for any other malignancy. Prognosis for a given patient depends on several factors. The...

Recurrent Childhood Rhabdomyosarcoma
Although patients with recurrent or progressive rhabdomyosarcoma can sometimes achieve complete remission with secondary therapy, the long-term prognosis for most is poor. The prognosis is most favorable (50%–70%, 5-year survival rates) for children who initially presented with stage 1 or Group I disease and embryonal histology and whohave local or regional recurrence....

Staging of rhabdomyosarcoma is relatively complex. The process includes:
Assigning a local tumor Group (status postsurgical resection/biopsy).
Assigning stage (consider site, size, Group, presence/absence of metastases).
Assigning a risk group (consider stage, Group, and histology). This page gives details of the staging system used by the Soft Tissue Sarcoma Committee of the Childrens...

Previously Untreated Childhood Rhabdomyosarcoma
Surgical Management Treatment Options

• Head and neck
• Extremity sites
• Truncal sites
• Genitourinary system
...
[Categories]
- OCOSH Classification: Bone Diseases: Orthopaedic Oncology: Connective and Soft Tissue Neoplasms: Muscle Tissue Neoplasms: Myosarcoma: Rhabdomyosarcoma 

Adult Non-Hodgkin's Lymphoma (PDQ®): Treatment
The NHLs are a heterogeneous group of lymphoproliferative malignancies with differing patterns of behavior and responses to treatment.[2] Like Hodgkin’s lymphoma, NHL usually originates in lymphoid tissues and can spread to other organs. NHL, however, is much less predictable than Hodgkin’s lymphoma and has a far...